Center for Health Systems Innovation

Medicine & Life Sciences

1. Systematic Reviews 100%
2. Fimbriae Proteins 81%
3. Meta-Analysis 81%
4. Electronic Health Records 72%
5. Smokers 68%
6. Primary Health Care 60%
7. Smoking Cessation 59%
8. Veterans 56%
9. Physicians 47%
10. Sepsis 43%
11. Data Mining 41%
12. Workload 40%
13. Delivery of Health Care 39%
14. Cross-Sectional Studies 37%
15. Escherichia coli K12 37%
16. Patient Protection and Affordable Care Act 37%
17. Systemic Inflammatory Response Syndrome 36%
18. Pneumocystis carinii 35%
19. Postoperative Nausea and Vomiting 34%
20. Workflow 33%
21. Diltiazem 32%
22. Achilles Tendon 32%
23. Dry Eye Syndromes 32%
24. Vietnam 32%
25. Membranes 32%
26. Nephrology 32%
27. Health 32%
28. Digoxin 32%
29. Diabetic Neuropathies 31%
30. Patient Readmission 31%
31. Primary Care Physicians 30%
32. Hormone Replacement Therapy 30%
33. Machine Learning 30%
34. Delayed Hypersensitivity 30%
35. Automobiles 29%
36. Hospital Emergency Service 28%
37. Hospital Mortality 28%
38. Diabetic Retinopathy 28%
39. Spouses 27%
40. Decision Trees 27%
41. Arousal 27%
42. Psoriasis 26%
43. Early Detection of Cancer 25%
44. Efficiency 24%
45. Atrial Fibrillation 24%
46. Chronic Obstructive Pulmonary Disease 24%
47. Rupture 23%
48. Mortality 22%
49. Single Nucleotide Polymorphism 22%
50. Coronary Artery Disease 22%
51. Quality of Life 21%
52. Randomized Controlled Trials 21%
53. Comorbidity 21%
54. Odds Ratio 20%
55. Peptides 20%
56. Medicaid 19%
57. Armed Conflicts 19%
58. Cohort Studies 18%
59. MEDLINE 18%
60. Workforce 18%
61. Pediatrics 17%
62. Breast Neoplasms 17%
63. Confidence Intervals 17%
64. Support Vector Machine 16%
65. Logistic Models 16%
66. Transportation of Patients 16%
67. Datasets 16%
68. Organizational Efficiency 15%
69. Therapeutics 14%
70. Fluticasone-Salmeterol Drug Combination 13%
71. Wounds and Injuries 13%
72. Quality Improvement 12%
73. Formoterol Fumarate 12%
74. Conjugated (USP) Estrogens 12%
75. Marital Status 12%
76. Medicare 11%
77. Budesonide 11%
78. T-Lymphocyte Subsets 11%
79. Pharmaceutical Preparations 11%
80. United States Health Resources and Services Administration 10%
81. Area Under Curve 10%
82. Research Personnel 10%
83. Smoking 10%
84. Amino Acids 10%
85. Proteins 9%
86. Healthcare Disparities 9%
87. Lyt antibodies 9%
88. Alkaline Phosphatase 9%
89. Pharmacology 9%
90. Clinical Decision-Making 8%
91. Urban Hospitals 8%
92. Fluorescein 8%
93. Length of Stay 8%
94. Health Literacy 8%
95. Technology 8%
96. anti-Thy antibody 8%
97. Appointments and Schedules 8%
98. Costs and Cost Analysis 8%
99. Pneumocystis Infections 8%
100. Patient-Centered Care 8%